A simple urine test can more than halve the number of cystoscopies necessary to follow up high-risk bladder cancer patients, new research has found. Cystoscopies involve inserting a flexible probe ...
Clinical study launched in June 2022 with patient recruitment in Alberta with plans to expand to further sites across North America. The aim of the study is to validate a novel and minimally invasive ...
DUARTE, Calif. (KABC) -- Bladder cancer affects 75,000 Americans every year. The most-telling symptom is usually blood in the urine. Even large tumors are curable, but the treatment can mean a drastic ...
A simple and cost-effective urine test could improve early detection and management of bladder cancer, according to a brief issued by the International Agency for Research on Cancer (IARC). This test ...
Patients with urinary incontinence, sudden and overwhelming urges to urinate, frequent urination and similar problems are usually given the traditional urodynamic test to measure how well the bladder ...
Results of the European multi-center study of Bladder EpiCheck ™ urine test, supporting reduction of invasive procedures, were published in the European Urology Oncology journal Nucleix Ltd., a ...
The Hearty Soul on MSN
Bladder cancer often starts quietly: 5 early symptoms to watch for
Bladder cancer does not always announce itself with dramatic pain or a sudden health crisis. In many people, the earliest bladder cancer symptoms look ordinary, brief, or easy to dismiss. A little ...
A urine test was shown to decrease the need for invasive cystoscopies in patients with non-muscle-invasive bladder cancer. A urine-based test may decrease the number of invasive cystoscopies in ...
Bright Uro Inc. this month received Food and Drug Administration approval for its first product, the Glean Urodynamics System. It’s the biggest milestone to date for the Irvine medical device maker ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc., (Nasdaq: VCYT) announced today the publication of new data demonstrating that the company’s Decipher Bladder genomic classifier accurately ...
For patients with the most serious form of bladder cancer, the standard of care has been to completely remove the bladder and adjacent organs. Now scientists at Massachusetts General Hospital (MGH) ...
REHOVOT, Israel, Jan. 30, 2019 /PRNewswire/ -- Nucleix Ltd., a leading cancer detection and screening company, announced today that Radboud University Medical Center (UMC) in Nijmegen, the Netherlands ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results